GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,263,000 | +339.5% | 19,653 | +111.8% | 0.11% | +197.3% |
| Q4 2019 | $970,000 | +6366.7% | 9,277 | +7036.2% | 0.04% | +3600.0% |
| Q3 2019 | $15,000 | -40.0% | 130 | -9.7% | 0.00% | 0.0% |
| Q2 2019 | $25,000 | -91.2% | 144 | -91.4% | 0.00% | -93.8% |
| Q1 2019 | $283,000 | -9.9% | 1,679 | -47.9% | 0.02% | -23.8% |
| Q4 2018 | $314,000 | -28.5% | 3,220 | +26.8% | 0.02% | -16.0% |
| Q3 2018 | $439,000 | -25.3% | 2,540 | -39.7% | 0.02% | -32.4% |
| Q2 2018 | $588,000 | +1.6% | 4,213 | -18.1% | 0.04% | -11.9% |
| Q1 2018 | $579,000 | +46.6% | 5,143 | +71.9% | 0.04% | +31.2% |
| Q4 2017 | $395,000 | +19.7% | 2,992 | +20.5% | 0.03% | -8.6% |
| Q3 2016 | $330,000 | +72.8% | 2,483 | -77.4% | 0.04% | +12.9% |
| Q3 2013 | $191,000 | – | 11,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |